PLD2
Basic information
Region (hg38): 17:4807152-4823434
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLD2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 61 | 68 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 1 | |||||
Total | 0 | 0 | 62 | 5 | 4 |
Variants in PLD2
This is a list of pathogenic ClinVar variants found in the PLD2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-4807793-C-G | not specified | Uncertain significance (Nov 17, 2022) | ||
17-4807795-T-C | not specified | Uncertain significance (May 08, 2023) | ||
17-4807821-T-G | not specified | Uncertain significance (Apr 25, 2022) | ||
17-4807836-A-G | not specified | Uncertain significance (Sep 24, 2024) | ||
17-4807843-C-T | not specified | Uncertain significance (Jan 04, 2024) | ||
17-4808013-T-A | not specified | Uncertain significance (Jun 05, 2024) | ||
17-4808284-G-A | not specified | Uncertain significance (Oct 05, 2022) | ||
17-4808301-C-T | not specified | Uncertain significance (Sep 27, 2022) | ||
17-4808346-C-A | not specified | Uncertain significance (Oct 12, 2024) | ||
17-4809126-G-A | not specified | Likely benign (May 26, 2024) | ||
17-4809134-G-T | not specified | Uncertain significance (Nov 04, 2023) | ||
17-4809138-A-G | not specified | Uncertain significance (Dec 27, 2023) | ||
17-4809140-A-G | not specified | Uncertain significance (Apr 22, 2022) | ||
17-4809161-C-T | not specified | Uncertain significance (Apr 25, 2023) | ||
17-4809346-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
17-4809499-T-C | not specified | Uncertain significance (Aug 28, 2023) | ||
17-4809542-G-T | not specified | Uncertain significance (Jun 12, 2023) | ||
17-4809548-G-A | not specified | Uncertain significance (May 09, 2024) | ||
17-4809723-A-G | not specified | Uncertain significance (Apr 20, 2024) | ||
17-4809753-G-A | not specified | Uncertain significance (Oct 06, 2021) | ||
17-4809887-G-T | not specified | Uncertain significance (Nov 09, 2024) | ||
17-4809990-C-T | not specified | Uncertain significance (Jul 21, 2021) | ||
17-4809999-G-A | not specified | Uncertain significance (Jul 16, 2024) | ||
17-4810001-C-T | Benign (Jul 11, 2018) | |||
17-4810007-G-A | not specified | Uncertain significance (Sep 27, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PLD2 | protein_coding | protein_coding | ENST00000263088 | 24 | 16339 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.14e-27 | 0.00703 | 125413 | 0 | 335 | 125748 | 0.00133 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.119 | 577 | 585 | 0.986 | 0.0000373 | 6031 |
Missense in Polyphen | 179 | 180.95 | 0.98922 | 1873 | ||
Synonymous | -0.154 | 237 | 234 | 1.01 | 0.0000143 | 1916 |
Loss of Function | 1.15 | 46 | 55.2 | 0.833 | 0.00000299 | 575 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00350 | 0.00350 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00131 | 0.00125 |
Finnish | 0.000739 | 0.000739 |
European (Non-Finnish) | 0.00139 | 0.00139 |
Middle Eastern | 0.00131 | 0.00125 |
South Asian | 0.000923 | 0.000915 |
Other | 0.00180 | 0.00179 |
dbNSFP
Source:
- Function
- FUNCTION: May have a role in signal-induced cytoskeletal regulation and/or endocytosis. {ECO:0000250}.;
- Pathway
- Fc gamma R-mediated phagocytosis - Homo sapiens (human);Ether lipid metabolism - Homo sapiens (human);Glycerophospholipid metabolism - Homo sapiens (human);Choline metabolism in cancer - Homo sapiens (human);Glutamatergic synapse - Homo sapiens (human);Endocytosis - Homo sapiens (human);GnRH signaling pathway - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Ras signaling pathway - Homo sapiens (human);Sphingolipid signaling pathway - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Phospholipid Biosynthesis;Ras Signaling;EGF-EGFR Signaling Pathway;metabolism of anandamide an endogenous cannabinoid;Metabolism of lipids;Role of phospholipids in phagocytosis;Fcgamma receptor (FCGR) dependent phagocytosis;Innate Immune System;Immune System;Metabolism;phospholipases;Phosphatidylinositol phosphate metabolism;Glycerophospholipid metabolism;EGFR1;ErbB1 downstream signaling;Arf1 pathway;Arf6 trafficking events;Angiopoietin receptor Tie2-mediated signaling;Glycerophospholipid biosynthesis;Phospholipid metabolism;Synthesis of PG;Synthesis of PA;mTOR signaling pathway;LPA receptor mediated events;Fc-epsilon receptor I signaling in mast cells;Arf6 downstream pathway;Alpha-synuclein signaling;IL8- and CXCR2-mediated signaling events;RhoA signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.253
Intolerance Scores
- loftool
- 0.929
- rvis_EVS
- 0.41
- rvis_percentile_EVS
- 76.56
Haploinsufficiency Scores
- pHI
- 0.336
- hipred
- Y
- hipred_score
- 0.621
- ghis
- 0.536
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.997
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Pld2
- Phenotype
- homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- phosphatidic acid biosynthetic process;cytoskeleton organization;small GTPase mediated signal transduction;lipid catabolic process;synaptic vesicle recycling;Fc-gamma receptor signaling pathway involved in phagocytosis;inositol lipid-mediated signaling;cell motility
- Cellular component
- endoplasmic reticulum membrane;Golgi apparatus;plasma membrane;presynapse
- Molecular function
- phospholipase D activity;protein binding;phosphatidylinositol binding;N-acylphosphatidylethanolamine-specific phospholipase D activity